Image_1_GSH-C4 Acts as Anti-inflammatory Drug in Different Models of Canonical and Cell Autonomous Inflammation Through NFκB Inhibition.tif
An imbalance in GSH/GSSG ratio represents a triggering event in pro-inflammatory cytokine production and inflammatory response. However, the molecular mechanism(s) through which GSH regulates macrophage and cell autonomous inflammation remains not deeply understood. Here, we investigated the effects of a derivative of GSH, the N-butanoyl glutathione (GSH-C4), a cell permeable compound, on lipopolisaccharide (LPS)-stimulated murine RAW 264.7 macrophages, and human macrophages. LPS alone induces a significant production of pro-inflammatory cytokines, such as IL-1β, IL-6, and TNF-α and a significant decrement of GSH content. Such events were significantly abrogated by treatment with GSH-C4. Moreover, GSH-C4 was highly efficient in buffering cell autonomous inflammatory status of aged C2C12 myotubes and 3T3-L1 adipocytes by suppressing the production of pro-inflammatory cytokines. We found that inflammation was paralleled by a strong induction of the phosphorylated form of NFκB, which translocates into the nucleus; a process that was also efficiently inhibited by the treatment with GSH-C4. Overall, the evidence suggests that GSH decrement is required for efficient activation of an inflammatory condition and, at the same time, GSH-C4 can be envisaged as a good candidate to abrogate such process, expanding the anti-inflammatory role of this molecule in chronic inflammatory states.
History
References
- https://doi.org//10.1016/S0006-2952(02)01176-0
- https://doi.org//10.3389/fphar.2014.00196
- https://doi.org//10.1186/s12937-016-0186-5
- https://doi.org//10.1017/S0029665100000847
- https://doi.org//10.1016/j.molimm.2004.09.029
- https://doi.org//10.1155/2016/6547248
- https://doi.org//10.3389/fimmu.2017.01239
- https://doi.org//10.1080/mccm.6.4.177.187
- https://doi.org//10.1007/s12035-014-8705-x
- https://doi.org//10.1016/j.intimp.2014.06.030
- https://doi.org//10.1006/cyto.1996.0152
- https://doi.org//10.1034/j.1399-3003.1999.14a17.x
- https://doi.org//10.1161/CIRCRESAHA.109.215715
- https://doi.org//10.3389/fimmu.2014.00514
- https://doi.org//10.3389/fimmu.2014.00614
- https://doi.org//10.1093/intimm/14.2.201
- https://doi.org//10.1016/j.jaci.2007.01.016
- https://doi.org//10.1371/journal.pone.0057866
- https://doi.org//10.3389/fimmu.2014.00071
- https://doi.org//10.1183/09031936.00.16593300
- https://doi.org//10.1089/152308601300185269
- https://doi.org//10.1074/jbc.M706145200
- https://doi.org//10.4049/jimmunol.179.7.4829
- https://doi.org//10.1038/cdd.2013.137
- https://doi.org//10.1155/2014/917698
- https://doi.org//10.1074/jbc.M710314200
- https://doi.org//10.2217/17460875.3.5.545
- https://doi.org//10.18632/oncotarget.8552
- https://doi.org//10.1091/mbc.e03-08-0585
- https://doi.org//10.1002/jcp.22542
- https://doi.org//10.1074/jbc.M113.506733
- https://doi.org//10.18632/aging.101139
- https://doi.org//10.1038/cddis.2014.458
- https://doi.org//10.1385/1-59259-816-1:129
- https://doi.org//10.3109/13813455.2012.705301
- https://doi.org//10.1016/j.jim.2013.04.009
- https://doi.org//10.1016/j.micinf.2007.03.002
- https://doi.org//10.3347/kjp.2008.46.3.145
- https://doi.org//10.1074/jbc.M109.005272
- https://doi.org//10.1002/jcb.23137
- https://doi.org//10.2174/1568026054985902
- https://doi.org//10.1016/j.ejphar.2012.10.019
- https://doi.org//10.3390/pr3010001
- https://doi.org//10.1161/ATVBAHA.108.179705
- https://doi.org//10.1016/j.bone.2015.03.015
- https://doi.org//10.3389/fneur.2016.00064
- https://doi.org//10.1016/j.tibs.2003.12.003
- https://doi.org//10.1146/annurev.immunol.18.1.621
- https://doi.org//10.1172/JCI26498
- https://doi.org//10.1152/ajpendo.00653.2006
- https://doi.org//10.1089/ars.2012.5149
- https://doi.org//10.3389/fphar.2014.00073
- https://doi.org//10.1073/pnas.87.12.4884
- https://doi.org//10.1093/jn/132.11.3286
- https://doi.org//10.1016/S1567-5769(02)00117-0
- https://doi.org//10.1007/s10753-008-9084-0
- https://doi.org//10.1016/j.intimp.2010.10.016
- https://doi.org//10.3389/fphys.2012.00161
- https://doi.org//10.1177/095632020401500204
- https://doi.org//10.1016/j.vaccine.2010.09.033
- https://doi.org//10.1016/j.vaccine.2011.07.101
- https://doi.org//10.1128/JVI.00603-16
- https://doi.org//10.1101/cshperspect.a001651
- https://doi.org//10.1186/1476-4598-12-86
- https://doi.org//10.1021/cr800554j
- https://doi.org//10.1615/CritRevEukarGeneExpr.v20.i2.10
- https://doi.org//10.1007/s12013-011-9182-8
- https://doi.org//10.4049/jimmunol.1100625
- https://doi.org//10.1128/MCB.10.4.1498
- https://doi.org//10.1016/j.lfs.2004.01.024
- https://doi.org//10.1016/j.atherosclerosis.2014.01.011
- https://doi.org//10.1042/CS20160005
- https://doi.org//10.1152/ajpregu.00467.2009
- https://doi.org//10.1172/JCI88880
- https://doi.org//10.1074/jbc.M601284200
- https://doi.org//10.1515/BC.2009.033
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity